Anthony Hunter, MD, Hematology, Atlanta, GA

AnthonyHunterMD

Hematology Atlanta, GA

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Assistant Professor, Emory University School of Medicine, Winship Cancer Institute

Dr. Hunter is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hunter's full profile

Already have an account?

Education & Training

  • University of South Florida Morsani College of Medicine
    University of South Florida Morsani College of MedicineFellowship, Hematology/Oncology, 2017 - 2020
  • Emory University
    Emory UniversityResidency, Internal Medicine, 2014 - 2017
  • Medical College of Wisconsin
    Medical College of WisconsinClass of 2014

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2020 - 2021
  • FL State Medical License
    FL State Medical License 2017 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Impact of TP53 gene Mutation Clearance and Conditioning Intensity on Outcome in MDS or AML Patients Prior to Allogeneic Stem Cell Transplantation
    Anthony Hunter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Patient Derived Xenografts (PDX) Recapitulate Ruxolitinib Clinical Trial Responses and Identify a Novel Combination Therapy for Chronic Myelomonocytic Leukemia (CMML)
    Anthony M. Hunter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Effects of the Therapeutic Armamentarium on Survival and Time to Next Treatment in CMML Subtypes: An International Analysis of 950 Cases Coordinated By the AGMT Study ...
    Anthony M. Hunter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • CSF3R Mutations Are Exceedingly Rare Genetic Events Associated with Inferior Survival and Sensitivity to Ruxolitinib across Myeloid Malignancies 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • WHO-Defined Chronic Myelomonocytic Leukemia-2 (CMML-2) Patients Rapidly Progress to AML Suggesting This Entity Represents a Transitory Clinical State 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • A Legacy of Tyrosine
    A Legacy of TyrosineMay 11th, 2020